Google Maps is likely your go-to app for getting from point A to point B, but it's more than a navigation tool. Whether you're finding places, checking public transit schedules, or exploring new ...

Though U.S. maps will reflect Trump's new name for the body of water, the rest of the world will continue calling it the Gulf of Mexico Win McNamee/Getty; Google Maps Google Maps will soon change ...

Here’s how it works. Apple Maps is one of the strongest navigation apps out there, despite it's rocky start. Having Apple Maps on your iPhone right out of the box makes it one of the most ...

Bluebird Bio’s Lyfgenia is listed at $3.1 million. Neither includes the cost of care to stay in the hospital or for chemotherapy. To manage the hefty price tag, insurers have implemented ...

The US FDA announced today that it has cleared two novel gene therapies for sickle cell disease: Vertex Pharmaceuticals' Casgevy and bluebird bio's Lyfgenia. The former is notably the first FDA ...

Google Maps is the name of the service, and it’s available in both mobile and desktop formats. There are not many people who don’t know about Google Maps. We’re here to take a closer look at ...

bluebird could fare better with its new cell-based gene therapy for SCD, Lyfgenia (lovotibeglogene autotemcel), which was cleared by the FDA in December and has a list price of $3.1 million.

The therapy was the first treatment to make it to market in the indication, closely followed by bluebird bio’s Lyfgenia (lovo-cel)—also a gene therapy. Less than six weeks later, Casgevy ...

This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily PharmaVoice newsletter. A number of first-in-disease, first-in-class and first ...

Its flagship product, LYFGENIA for SCD, is at the forefront of its commercialization efforts. LYFGENIA is a one-time gene therapy to treat sickle cell disease in individuals 12 years of age or ...

Children's Hospital Los Angeles added a 10th cell and gene therapy treatment for children, adolescents and young adults with serious medical conditions. The newest gene therapy treatment, Casgevy ...